Methylation profiling identified novel differentially methylated markers including OPCML and FLRT2 in prostate cancer

To develop new methods to distinguish indolent from aggressive prostate cancers (PCa), we utilized comprehensive high-throughput array-based relative methylation (CHARM) assay to identify differentially methylated regions (DMRs) throughout the genome, including both CpG island (CGI) and non-CGI regi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Epigenetics
Autors principals: Wu, Yu, Davison, Jerry, Qu, Xiaoyu, Morrissey, Colm, Storer, Barry, Brown, Lisha, Vessella, Robert, Nelson, Peter, Fang, Min
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4889305/
https://ncbi.nlm.nih.gov/pubmed/26890304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2016.1148867
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars